Clinical Trial Update: Immunogenicity and Safety of Verorab™ in Indian Population [Phase 4]

View source ↗

Summary

Phase 4 study assessing immunogenicity and safety of Verorab rabies vaccine in an Indian population has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Verorab (rabies vaccine (inactivated))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Rabies | Phase 4 | Status: COMPLETED